---
Media

Awakn in the Media

Asset-15

ITV News - How psychedelic-assisted psychotherapy has the potential to revolutionize the treatment of Addiction & other MentalHealth conditions

Asset-12

The Times - Can Ketamine help cure alcoholism

Asset-17

The Evening Standard - Inside London’s first psychedelic psychotherapy clinic

Asset-13

ABC - How Awakn’s MDMA-assisted psychotherapy research has the potential to help patients with Addictions and Mental illness to overcome trauma.

Asset-14

Vice - The future of medicine will be drugs you never heard of

Asset-11

Forbes - Ketamine to treat gambling addiction - Anthony Tennyson

Asset-10

Business Insider - Scientists say ketamine could help people quit alcohol after 'encouraging' study

Asset-1

Psychedelic spotlight - the 5 most influential psychedelic studies in the world
 

Asset-9

Triggernometry - Prof. David Nutt - The truth about drugs 

Asset-8

Medscape - Ketamine an intriguing new therapy for alcoholics

Asset-7

The Naked scientists - Prof Nutt - What psychedelics do to your brain 

Asset-6

Pharmacy Times - Prof Celia Morgan - The future of Ketamine-assisted therapy

Asset-3

Technology Networks - Anthony Tennyson and Prof. David Nutt - Treating addiction with Psychedelics

Asset-4

New Atlas - Highlighting groundbreaking studies in psychedelics

Asset-5

The Dales Report -  A new hope for Alcoholics

Asset-2

Free think media - Ketamine therapy may help drinkers stay abstinent
 

Logo resources

Awakn Life
Sciences Corp.

logo3

Sign Up for Newsletter

Awakn_logo_corp

MAIN OFFICE
Awakn Life Sciences Corp.
301-217 Queen St. W
Toronto, Ontario M5V 0R2
Canada

© 2023 Awakn Life Sciences Corp      |      Privacy Policy      |      Disclaimer

Back to top Arrow